Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP13155433.9

公开号：

EP2604277A1

申请日:

2008.10.13

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/